Back
Cronos Group Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
29
CRON
Cronos Group
Last Price:
$1.96
Seasonality Move:
35.39%
Buy
56
AUPH
Aurinia Pharmaceuticals
Last Price:
$9.04
Seasonality Move:
22.59%
Sell
29
Cronos Group (CRON)
is a Sell
Is Cronos Group a Buy, Sell or Hold?
-
The current Cronos Group [CRON] share price is $1.96. The Score for CRON is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
CRON is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
-
The current Aurinia Pharmaceuticals [AUPH] share price is $9.03. The Score for AUPH is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
AUPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRON Stock Price Chart
What is Cronos Group's stock price today?
-
The Cronos Group share price today is $1.96Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRON is experiencing buying pressure, which is a positive indicator for future bullish movement.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $9.03The current trend is moderately bearish and AUPH is experiencing slight selling pressure.
CRON Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.05 | Sell |
Relative Strength Index (14 RSI): | 44.29 | Sell |
Chaikin Money Flow: | 1380617 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.95 - 2.07) | Sell |
Bollinger Bands (100): | (2.04 - 2.28) | Sell |
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.3 | Buy |
Relative Strength Index (14 RSI): | 51.75 | Buy |
Chaikin Money Flow: | -459691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.42 - 9.56) | Buy |
Bollinger Bands (100): | (6.26 - 8.56) | Buy |
CRON Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.93 | Buy |
20-day SMA: | 2.01 | Sell |
50-day SMA: | 2.08 | Sell |
200-day SMA: | 2.32 | Sell |
8-day EMA: | 1.94 | Buy |
20-day EMA: | 1.99 | Sell |
50-day EMA: | 2.06 | Sell |
200-day EMA: | 2.2 | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.44 | Sell |
20-day SMA: | 9.18 | Sell |
50-day SMA: | 8.24 | Buy |
200-day SMA: | 6.37 | Buy |
8-day EMA: | 9.27 | Sell |
20-day EMA: | 9.09 | Sell |
50-day EMA: | 8.42 | Buy |
200-day EMA: | 7.26 | Buy |
Cronos Group Earnings Growth & CRON Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.02 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
Cronos Group Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aurinia Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |